NiaHealth

NiaHealth provides advanced health monitoring services through a subscription model, utilizing biomarker analysis to enhance health outcomes and prevent disease for users across Canada. NiaHealth, founded in 2023 in Edmonton, Canada, delivers health monitoring services through advanced biomarker testing. The company recently pivoted to include a subscription model aimed at health-conscious individuals. In June 2025, NiaHealth raised CAD 5.

75 million in seed funding led by new investor Golden Ventures, with participation from another new investor 51 Ventures. Returning investors Version One Ventures, ScaleGood, Garage Capital, individual and other unspecified investors also participated in the round. The founder had previously established other health-focused ventures, enhancing their expertise in the industry. NiaHealth offers advanced health monitoring services through a subscription model, focusing on the proactive assessment of biomarkers to optimize health outcomes and prevent disease.

Their core product offerings include comprehensive blood tests that analyze over 50 biomarkers related to cardiovascular health, metabolic function, liver and kidney health, and hormonal balance. The service is designed for health-conscious individuals seeking insights into their health status, with a focus on early detection of potential health issues. NiaHealth serves a diverse clientele in Canada’s provinces of Ontario, Manitoba, Alberta, and British Columbia, providing both at-home blood draw services and in-clinic testing options. The company emphasizes personalized health strategies, offering tailored recommendations based on the results of the biomarker tests.

NiaHealth operates on a subscription-based revenue model, charging annual fees for its health monitoring services. Their pricing plans include the Essential Plan at CAD 299 per year, the Plus Plan at CAD 599 per year, and the Optimum Plan at CAD 1,299 per year, catering to varying health optimization needs. Each plan includes a set number of biomarker tests and personalized health assessments, with additional fees applicable for mobile blood draw services in certain regions. Revenue is generated directly from consumers, with clients purchasing subscriptions that provide access to comprehensive health insights and ongoing support from a dedicated clinical team.

This structure emphasizes direct-to-consumer engagement, allowing users to manage their health proactively and receive tailored guidance based on their unique health data. The company plans to utilize the June 2025 funding to launch NiaHealth Platform 2. 0, enhance R&D for predictive features, develop AI clinician support tools, and grow its user base in Canada.